People with diabetes cancer prevalence rate increased significantly

The 2017-03-14

Source: health

Report from our correspondent (chief reporter Tan Jia) a involving more than 250000 people in China, according to the results of multicenter, prospective observational study of sugar metabolic abnormalities associated with a significant part of the increased risk of malignant tumor, diabetes duration, insulin resistance and also part of the malignant tumor associated with an increased risk of illness. In the recently held in wuxi city, jiangsu province, 2017 east China endocrine metabolic disease on the BBS, the expert reminds, clinicians and diabetic patients in the control of blood sugar at the same time, also attaches great importance to the associated part of the tumor with annual check-up.

According to introducing, ruijin hospital affiliated to Shanghai jiaotong university school of medicine, professor NingGuang led to carry out the Chinese patients with type 2 diabetes risk tumor epidemiology registered research (REACTION). From 2011 to 2017, 25 medical institutions through developing cohort study community cluster random sampling, a total of survey, 259000 people, with an average age of 57-10 years old, 34.67% of men, women accounted for 65.33%. The study plan for different sugar metabolism people without history of malignant tumor were followed for more than five years, 3 years follow-up by the year 2015 has been completed.

Ruijin hospital affiliated to Shanghai jiaotong university school of medicine, endocrinology Wang Weiqing professor introduction, looked from the present study, patients with diabetes all malignant tumors had a significantly higher prevalence of pre-diabetes and normal glucose tolerance. Men normal glucose tolerance group all malignant tumor incidence was 1.02%, pre-diabetes populations was 1.05%, patients with diabetes is 1.45%; Women are 1.86%, 2.17% and 1.86% respectively. Men with diabetes prevalence rate increased significantly in the four major malignant tumor, lung cancer, bladder cancer and kidney cancer, colorectal cancer is women for breast cancer, endometrial cancer, colorectal cancer and ovarian cancer.

In the course of the disease, in all patients with diabetes, the course of more than 10 years with colorectal cancer and significantly associated with an increased risk of kidney cancer, bladder cancer. Men with diabetes, the course of more than 5 years and significantly associated with an increased risk of colorectal cancer; Women with diabetes, the course of more than 10 years and significantly associated with an increased risk of endometrial cancer, ovarian cancer. In addition, in non-diabetic women crowd, relative to the insulin sensitivity, and insulin resistance of female breast cancer, ovarian cancer and endometrial cancer risk increases.